• Go to navigation
  • Go to content

Syn2bio

  • Syn2bio
  • SYN2 Cardiotracer
    • Medical context
    • What is SYN2
    • SYN2’s advantages
    • Research history
  • Investor relations
    • Shares on the WSE
    • Current reports
    • Corporate Governance
    • General Meetings
    • Division of Synektik SA
    • Public offering
    • Investor calendar
    • IR contact
  • News
  • Contact
  • pl

News

  • Homepage
  • >ESPI
  • All
  • Corporate news
  • Investor relations

ESPI

2026-04-09

Notification of transactions on the Issuer’s shares

2026-04-08

Receipt of notification pursuant to Article 69 of the Act on Public Offering – change in the status of ownership of the Issuer’s shares

2026-04-08

Notification of transactions on the Issuer’s shares

2026-04-08

Receipt of notification pursuant to Article 69 of the Act on Public Offering – change in the status of ownership of the Issuer’s shares

2026-03-30

Fulfilment of the condition for the Issuer’s shares to be admitted to trading

2026-03-30

Registration of the increase in the Issuer’s share capital and amendments to the Issuer’s Articles of Association in connection with the division of Synektik SA

<
  • 1
  • 2
>
  • Syn2bio
  • SYN2 Cardiotracer
  • Investor relations
  • News
Syn2bio SA
ul. J. P. Dziekońskiego 3
00-728 Warszawa

phone: +48 22 327 09 10

e-mail: kontakt@syn2bio.pl

  • Privacy and cookie policy
© 2026 Syn2bio